(1 - 11 von 12
)
uniQure N.V.: uniQure Announces Company Participation at Citi...
www.finanznachrichten.de
Matt Kapusta, chief executive officer of uniQure, will participate on the analyst-moderated panel entitled, "Gene-Therapy Manufacturing and ...
uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of...
www.hemophiliafed.org
“Our mission in hemophilia B has always been to be first to market with a best-in-class gene therapy,” said Matt Kapusta, chief executive officer.
uniQure : Announces Management and Board Changes | MarketScreener
www.marketscreener.com
Lexington, MA and Amsterdam, the Netherlands, September 22, uniQure N.V. , a leader in human gene therapy, today announced that its Board of Directors...
uniQure Announces Management and Board Changes
www.globenewswire.com
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Sept. ...
sortiert nach Relevanz / Datum